Results 211 to 220 of about 42,056 (305)

CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target

Experimental Dermatology, Volume 35, Issue 5, May 2026.
ABSTRACT Immune checkpoint inhibitors have transformed the treatment of advanced melanoma, yet many patients develop primary or acquired resistance. Although most work has focused on adaptive checkpoints (PD‐1 and CTLA‐4), accumulating evidence implicates innate immune suppression and stem‐like, drug‐resistant melanoma cell states.
Claudia Lasalle, Rachel C. Chang, Nicole C. Nowak, Yulu Wang, Alessio Giubellino, Kyle T. Amber, Adrian P. Mansini   +6 more
wiley   +1 more source

CMAH-Targeted Knock-In of Inducible Heme Oxygenase-1 and Constitutive CD47 in GGTA1-Knockout Pigs for Xenotransplantation. [PDF]

Xenotransplantation
Lee H, Kim SE, Lee WK, Oh M, Lee S, No JG, Park MR, Kim S, Do MH, Oh KB.   +9 more
europepmc   +1 more source

CD47 Antagonist ALX148 [PDF]

, 2020
openaire   +1 more source

Matrifibrocytes Redefine Cardiac Fibrosis: From Terminal Differentiation to Translational Modulation

Journal of Cellular and Molecular Medicine, Volume 30, Issue 10, May 2026.
ABSTRACT Cardiac fibrosis is increasingly recognized as a dynamic program that resolves into a terminal fibroblast fate, the matrifibrocyte, rather than a persistent myofibroblast state. Lineage‐tracing and single‐cell studies reveal that matrifibrocytes arise from activated myofibroblasts during late scar maturation, lose α‐SMA and proliferative ...
Zhentao Zhang, Hua Zhu
wiley   +1 more source

The SIRP family: from structural diversity and signaling mechanisms to implications in immune-related disease targeted therapeutics. [PDF]

Front Immunol
Jin Y, Huang Q, Song J, Abideen ZU, Tan R, Xu S, Chen M.   +6 more
europepmc   +1 more source

CD47 wt Allele [PDF]

, 2020
openaire   +1 more source

Podophyllotoxin sensitizes triple-negative breast cancer cells to CD47-targeted immunotherapy. [PDF]

Cell Insight
Dang J, Song N, Zhou J, Raoof M, Feng M.
europepmc   +1 more source

Thrombospondins in the heart: potential functions in cardiac remodeling [PDF]

, 2009
Mark W. M. Schellings, Geert C. van Almen, E. Helene Sage, Stephane Heymans, A Agah, A Agah, D Albo, LC Armstrong, LC Armstrong, D Bansal, S Belmadani, G Bendig, WM Blankesteijn, P Bornstein, E Braunwald, MJ Calzada, MJ Calzada, W Casscells, L Chandrasekaran, K Chatila, H Chaulet, J Chen, J Cleutjens, AR Collins, M Crabos, SE Crawford, O Dewald, LA DiMichele, M Dobaczewski, S Donnini, M Eghbali, H Emonard, NG Frangogiannis, NG Frangogiannis, V Gahtan, AG Gao, MO Gray, S Gupta, J Hao, R Heimer, S Hein, J Heineke, O Hudlicka, LJ Ignarro, JS Isenberg, JS Isenberg, JS Isenberg, JS Isenberg, JS Isenberg, JS Isenberg, JS Isenberg, R Karch, W Koch, MM Krady, HC Krutzsch, TR Kyriakides, TR Kyriakides, H Lal, L Lamy, B Lange-Asschenfeldt, T Lee, PJ Lijnen, H Lu, S Maclauchlan, MH Malek, AM Manso, S Miyata, E Mustonen, X Qian, R Rastaldo, LA Ridnour, JC Rodriguez-Manzaneque, S Rosenkranz, J Rysa, AP Sappino, MW Schellings, MW Schellings, M Schiller, W Schorb, B Schroen, S Schultz-Cherry, SY Shai, M Shimazaki, I Shiojima, R Simantov, R Simantov, FG Spinale, I Staniszewska, J Sun, B Swynghedauw, N Takahashi, FL Tan, G Taraboletti, NL Thompson, K Tokuda, JJ Tomasek, H Tomita, EJ Topol, NA Trueblood, RS Vasan, FJ Villarreal, FJ Villarreal, FJ Villarreal, D Wang, XJ Wang, RA Weir, DE White, M Wunsch, Z Yang, Z Yang   +109 more
core   +1 more source

Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents. [PDF]

Front Immunol
Li N, Yu J, Wang R, Gong G.
europepmc   +1 more source

Engineering macrophages for effective and safe targeting of CD47 cancer cells in the tumor microenvironment. [PDF]

J Immunother Cancer
Andón FT, Rosales Sánchez A, Pensado-López A, García-Campelo R, Takimoto CH.   +4 more
europepmc   +1 more source